RESUMEN

【Objective】 To determine the reference red blood cells with weak agglutination intensity of low positive quality control products by comparing RhD antigen expression intensity difference according to the serological results. 【Methods】 The RhD(+ ) red blood cells were detected by microcolumn gel method with 1 500 times diluted anti-D typing reagent. The samples with weak and strong RhD antigen expression intensity were selected as the reference red blood cells for weak agglutination intensity of low positive quality control products, and verification was performed. 【Results】 Ten RhD(+ ) red blood cells were detected with diluted anti-D typing reagent, of which 8 were 1+ and 2 were ±. Red blood cells with agglutination intensity of 1+ were used as the benchmark to determine the maximum dilution ratio of anti-D typing reagent when their agglutination intensity was 1+. As the preparation standard of low positive quality control products, the agglutination intensity of red blood cells with low RhD antigen expression intensity was extremely weak ±, which was difficult to ensure the stability of its control limit properties. Based on red blood cells with agglutination intensity of ±, the maximum dilution ratio of anti-D typing reagent with agglutination intensity of 1+ was re-determined as the preparation standard of low positive quality control products, and the results met the requirements of quality control product setting. 【Conclusion】 Using red blood cells with low RhD antigen expression intensity as the benchmark to set the weak agglutination intensity of the low positive quality control products can avoid the loss of control due to the low target value.

RESUMEN

【Objective】 To detect the piperacillin and amoxicillin antibodies in suspicious blood samples from pre-transfusion compatibility tests in Wuxi and analyze the general characteristics of them, so as to eliminate the interference of drug-induced antibodies with compatibility tests and provide reference for safe and effective blood transfusion, 【Methods】 Drug-sensitized RBCs and low-ion anti-globulin microcolumn gels were used to detect piperacillin and amoxicillin antibodies in 128 plasma samples which were initially undetermined in pre-transfusion compatibility tests. Data were analyzed by Chi-square test or fisher′s exact test. P<0.05 was statistically significant. 【Results】 Among these 128 undetermined samples, including 31 cases of type A, 48 type B, 14 type AB and 35 type O, the overall positive rate of piperacillin and amoxicillin antibodies was 28.9%(37/128), in which the positive rates of piperacillin and amoxicillin antibodies were 20.3%(26/128) and 8.6%(11/128), respectively. The difference between these two drug-induced antibodies was significant(P<0.05). Further analysis showed that the piperacillin antibodies in patients over 50 years old was 25.3%(24/95), while under 50 years old was 6.1%(2/33)(P<0.05). In contrast, the amoxicillin antibodies in patients over 50 years old was 5.3%(5/95), while under 50 years old was 18.2%(6/33), with statistically significant differences between each other(P<0.05). 【Conclusions】 In patients with suspicious antibodies in pre-transfusion detection, except for the allotype antibodies, drug-induced antibodies should be more considered in combination with medication history to better ensure the safety and effectiveness of blood transfusion.

RESUMEN

Anti-human globulin (AHG) reagents are widely applied in pretransfusion compatibility tests. The accuracy of detection with AHG reagents is mainly affected by irregular antibodies or cold agglutinins in blood samples, which are related to the human complement system. Although much has been written about various types and applications of AHG reagents, their characteristics, interference factors and optimal selection in pretransfusion compatibility tests still need to be further clarified. Here, we review clinical practice and basic studies that describe each AHG reagent, summarize the advantages and disadvantages of using different AHG reagents in the presence of cold agglutinins or complement-fixing antibodies, explore the potential mechanisms by which the complement system influences detection with AHG reagents and address the question of how to optimally select AHG reagents for clinically significant antibody detection.

Asunto(s)

RESUMEN

【Objective】 To establish the maximum surgical blood order schedule(MSBOS) for orthopedic surgery, as to guide the clinical blood application and reasonable blood preparation for this type of surgery. 【Methods】 The ordered and actual amount of transfused blood of orthopedic elective operations in our hospital from 2014 to 2018 were collected by the hospital information(HIS) and blood collection information software of Department of Blood Transfusion.The surgeries were classified and indices, including blood transfusion rate and per capita transfused RBC volume, were calculated, then orthopedic MSBOS was established by combining the surgical transfusion rate, per capita red blood cell infusion volume, the algorithm of MSBOS, the risk of massive hemorrhage and the actual situation of our hospital. 【Results】 A total of 3 730 cases of elective orthopedic surgery were included, and the ordered blood volume was 10 183.8 U. 1084 cases received intraoperative blood transfusion, with the total blood transfusion volume of 3 498.8 U and the blood transfusion rate at 29.1%(1 084/3 730). The blood transfusion volume of surgical patients was [1~17.5(3.21±1.89)] U/patient. MSBOS for orthopedic surgeries had been established in our hospital. According to the blood transfusion data of each surgical procedures, surgical blood ordering was divide into 2 categories: Type/Screen, Type/Screen/Crossmatch (2~8 U). 【Conclusion】 The establishment of MSBOS in Department of Blood Transfusion according to the daily blood use in orthopedic surgery is not only beneficial to guide the blood preparation for orthopedics surgery more scientifically and reasonably, but also can optimize the management of blood inventory and provide reference for the establishment of MSBOS in other blood use departments.

Asunto(s)

RESUMEN

An electrochemical access to iodinated aromatic compounds starting from trimethylsilyl-substituted arenes is presented. By design of experiments, highly efficient and mild conditions were identified for a wide range of substrates. A functional group stability test and the synthesis of an important 3-iodobenzylguanidine radiotracer illustrate the scope of this process.

RESUMEN

BACKGROUND: When unpredicted surgical blood loss occurs, it is essential that blood arrive from the blood bank in a timely manner. OBJECTIVE: To evaluate the turnaround time (TAT) for red blood cells (RBCs) from the blood bank to the operating suite. Cases with delayed TATs were further analyzed to determine potential causes for the delays. METHODS: During a 6-month period, intraoperative RBC requests were included among the blood component request lists at a single tertiary care hospital. RESULTS: A total of 387 RBC-product requests were received from the operating room, of which 220 (56.8%) cases were intraoperative requests. The overall mean (SD) TAT was 19.4 (9.8) minutes. Mean (SD) preparation-to-issuance time (14.9 [7.8] minutes) contributed more to the overall TAT than did mean (SD) request-to-preparation time (4.5 [7.4] minutes). The 31 cases (14.1%) exceeded the internally mandated TAT threshold (> 30 minutes). Prolonged compatibility testing and delayed courier arrival contributed to TAT delay. CONCLUSIONS: TAT standards for issuing RBCs from the blood bank to the operating suite should be established and carefully monitored for quality improvement of transfusion services.

Asunto(s)

RESUMEN

OBJECTIVE: To optimize the formulation of self-microemulsion containing total saponins from Lysimachia capillipes by central composite design-response surface methodology. METHODS: Based on the study of solubility, compatibility test and ternary phase diagram, central composite design-response surface methodology was adopted to optimize the best prescription with the emulsifying time, particle size, and Zeta pontential as indexes, physicochemical properties of this self-microemulsion were also determined. RESULTS: Optimum formulation was 12.93% of ethyl oleate, 57.25% of Kolliphor RH40, 29.82% of Transcutol. The a verage particle size, polydispersity index, Zeta pontential and drug loading of self-microemulsion containing total saponins from Lysimachia capillipes were 23.0 nm, 0.160, -20.28 mV and 10.52 mg·g-1.CONCLUSION: With good predictability, this methods can be used for the formulation optimization of self-microemulsion loaded total saponins from Lysimachia capillipes.

RESUMEN

In this work, antibiotic drug Minocycline (Mic) loaded cellulose nano-whiskers (CNWs)/poly(sodium acrylate) hydrogel films were prepared and investigated for their drug releasing capacity in physiological buffer solution (PBS) at 37 °C. The (CNWs)/poly(sodium acrylate) film, containing 9.7% (w/w) of CNWs, demonstrated Mic release of 2500 µg/g while the plain poly(acrylate) film showed 3100 µg/g of drug release. In addition, with the increase in the concentration of cross-linker N,N'-methylene bisacrylamide (MB) from to, the drug release from the resulting films decreased from 507 to 191 µg/g. The release exponent 'n' for films with different compositions was found in the range of 0.45 to 0.89, thus indicating non-Fickian release mechanism. The Schott model was employed to interpret the kinetic drug release data successfully. The film samples poly(SA) and CNWs/poly(SA) (both not containing drug) showed thrombus formation of 0.010±0.001 g and 0.007±0.001 g, respectively, thus showing the non-thrombogenic behavior. In percent Hemolysis, both of the film samples of 1.136±0.012 and 0.5±0.020, respectively, thus indicating non-hemolytic behavior. In addition, both of the film samples demonstrated protein adsorption of 49.02±0.59µ g/µL and 51.20±0.51 µg/µL per cm(2), thus revealing a fair degree of protein adsorption. Finally, the Mic-loaded films showed fair anti-fungal and antibacterial properties.

Asunto(s)

RESUMEN

Objective: To study the prescription and preparation technology of tea tree oil (TTO) microemulsion gel. The quality and the stability were evaluated. Methods: The prescription and preparation technology were selected and optimized through the compatibility test and the pseudo-ternary phase diagram. TTO microemulsion gel was prepared by adding gelatin. The appearance, pH value, viscosity, moisture rate, and the drug concentration were evaluated. Results: The prescription composition of TTO microemulsion gel was TTO (0.6%), Cremophor RH-40 (1.2%), PEG 400 (0.2%), carbopol-980 (0.2%), glycerol (2%), with distilled water adding to 50 g. The optimum formulation exhibited clear and transparent, uniform exquisite, moderate viscosity, and well spreadable, with the particle diameter of (38.38 ± 2.30) nm, zeta potential of (-56.00 ± 5.82) mV, pH value of 5.52 ± 0.01, viscosity of (48 834 ± 5) Pa·s, moisture rate of (96.74 ± 0.52)%, and the drug-loaded of (5.79 ± 0.03) mg/g. The result of heat and cold resistance test showed that the preparation was needed to be stored at low-temperature. Conclusion: The preparation of TTO microemulsion gel is simple, corresponding to the main index of gelata for topical drug delivery preparation and offering the basis for further research and development.

RESUMEN

Sequence comparison is one of the foundations in bioinformatics, which can be used to study evolutionary relations among the sequences. In this study, a 2D spectrum-like graphical representation of protein sequences is presented based on the hydrophobicity scale of amino acids. The frequencies of amplitudes of 4-subsequences are adopted to characterize a spectrum-like graph, and a 17D vector is used as the descriptor of protein sequence. The χ(2) value of compatibility test is performed. New similarity analysis approach is illustrated on the all protein sequences, which are encoded by the mitochondrion genome of 20 different species. Finally, comparison with the ClustalW method shows the utility of our method.

RESUMEN

BACKGROUND: The growing awareness of transfusion-associated morbidity and mortality necessitates investigations into the underlying mechanisms. Small animals have been the dominant transfusion model but have associated limitations. This study aimed to develop a comprehensive large animal (ovine) model of transfusion encompassing: blood collection, processing and storage, compatibility testing right through to post-transfusion outcomes. MATERIALS AND METHODS: Two units of blood were collected from each of 12 adult male Merino sheep and processed into 24 ovine-packed red blood cell (PRBC) units. Baseline haematological parameters of ovine blood and PRBC cells were analysed. Biochemical changes in ovine PRBCs were characterized during the 42-day storage period. Immunological compatibility of the blood was confirmed with sera from potential recipient sheep, using a saline and albumin agglutination cross-match. Following confirmation of compatibility, each recipient sheep (n = 12) was transfused with two units of ovine PRBC. RESULTS: Procedures for collecting, processing, cross-matching and transfusing ovine blood were established. Although ovine red blood cells are smaller and higher in number, their mean cell haemoglobin concentration is similar to human red blood cells. Ovine PRBC showed improved storage properties in saline-adenine-glucose-mannitol (SAG-M) compared with previous human PRBC studies. Seventy-six compatibility tests were performed and 17·1% were incompatible. Only cross-match compatible ovine PRBC were transfused and no adverse reactions were observed. CONCLUSION: These findings demonstrate the utility of the ovine model for future blood transfusion studies and highlight the importance of compatibility testing in animal models involving homologous transfusions.

Asunto(s)

RESUMEN

O estudo de filmes de Carbono tipo Diamante é objeto de pesquisas devido às suas diferentes propriedades incluindo propriedades antibacterianas. No tratamento reabilitador com implantes, podem ocorrer complicações, proporcionando a infiltração de microrganismos orais para a interface Implante-Componente protético. O objetivo deste estudo foi avaliar propriedades de molhabilidade e energia livre de superfície a partir dos valores do ângulo de contato; propriedades antimicrobiana, de bioadesão e citotoxicidade de discos de titânio recobertos com DLC. Escherichia coli foi mantida em meio BHI a 37ºC por 3 h e 24 h para teste antimicrobiano. Para adesão, os discos foram mantidos em cultura de E. coli por 90 minutos a 37ºC e 20 minutos em ultrassom. A capacidade de prevenção na migração de bactérias para o interior da interface Implante-Componente protético foi realizado em implantes Hexágono Externo, conectados com torque de 32N e deixados em contato com E. coli por 24h, e Reação em Cadeia da Polimerase semi-quantitativo foi realizado para confirmação da esterilidade da técnica. Foram quantificados em UFC/mL em BHI Ágar para o teste antimicrobiano, adesão e infiltração bacteriana. Para citotoxicidade foi utilizado queratinócitos humanos (HaCat) cultivados em meio DMEM mantidos em atmosfera com 5% de CO2 a 37°C e avaliados pelo teste colorimétrico MTT. Os resultados de molhabilidade, teste antimicrobiano, teste de adesão e Infiltração bacteriana não apresentaram diferença estatisticamente significante entre os grupos. As superfícies de titânio e recobertas com DLC apresentaram uma leve diminuição na viabilidade celular com diferença estatisticamente significante ao grupo controle. O DLC apresenta-se como material biocompatível com leve grau de citotoxicidade que não modifica as propriedades de superfície, não apresenta propriedades antimicrobianas, não interfere na adesão bacteriana de E. coli e não inibem a infiltração bacteriana na interface implante-componente protético

The study of DLC films is the subject of research due to their different properties including antibacterial properties. Rehabilitator in implant treatment, complications may occur, providing the infiltration of oral microorganisms for implant- abutmente interface. The aim of this study was to evaluate properties and wetting surface free energy from the values of the contact angle; antimicrobial properties bioadhesion and cytotoxicity of titanium discs coated with DLC. Escherichia coli was maintained on BHI at 37 ° C for 3 h and 24 h for antimicrobial test. For adhesion test, the discs were maintained in culture of E. coli for 90 minutes at 37 ° C and 20 minutes inside ultrasound. The ability to prevent the migration of bacteria into the implant - abutment interface was performed in dental implants External Hexagon connected with a torque of 32N and left in contact with E. coli for 24 h , and Polymerase Chain Reaction semi -quantitative was performed to confirm the sterility of the technique. Were quantified in CFU / ml in BHI agar for antimicrobial test, bacterial adhesion and infiltration. Cytotoxicity was performed using human keratinocytes ( HaCaT ) cultured in DMEM maintained in an atmosphere of 5% CO2 at 37 ° C and evaluated by the MTT colorimetric assay. The results of wettability, antimicrobial test, adhesion test and bacterial infiltration showed no statistically significant difference between the test groups. The surfaces of titanium and coated with DLC showed a slight decrease in cell viability with a statistically significant difference to the control group. The DLC is presented as biocompatible material with mild cytotoxicity without changing the surface properties, has no antimicrobial properties, does not interfere with bacterial adherence for E. coli and do not inhibit bacterial infiltration into the implant-abutment interface

Asunto(s)

RESUMEN

Objective: To investigate the components adsorbability of Shuangbai Film Spraying Agent (SFSA) packaged by three types of plastic medicinal materials, and to optimize the packaging material for SFSA. Methods: SFSA was dispensed in polyethylene terephthalate (PET), polypropylene (PP), and high density polyethylene (HDPE) plastic spraying bottles and the factors influencing test and conventional sample test were carried out. The characteristics of sample solution and spraying bottles and the internal color of spraying bottles were inspected, the optimal packaging material was screened for compatibility long-term test, the wall color changes of spraying bottles were observed, and the contents of drug concentration and the bottle wall adsorption were determined by HPLC. Results: The degree of change in color after six months of the three types of drug packaging material was HDPE > PP > PET; The hardness and impact strength of PP bottle decreased. PET bottles only adsorbed small quantities of aloe-emodin, rhein, emodin, chrysophanol, emodin, and none of the other ingredients. The chrysophanol and emodin were unstable in the aqueous solution, and the contents of other indicator components of SFSA in the PET bottle were stable. Conclusion: PET is suitable to be the packaging materials of SFSA.

RESUMEN

PURPOSE: Because vascular access sites in neonates are limited, intravenous (IV) medications must often be mixed with maintenance fluids, including parenteral nutrient (PN) solutions. This study was done to determine whether IV medications commonly prescribed in the neonatal in- tensive care unit (NICU) are compatible with the two neonatal PN solutions. METHODS: The compatibility of neonatal PN solutions and selected other drugs during Y-site delivery was evaluated. Secondary drugs were administered at selected concentrations, rates and delivery by method commonly used at the NICU. Drugs administered by syringe pump over 30min : amikacin, cefotaxime, ceftriaxone, piperacillin, phenytoin, aminophylline, ceftazidime, fluconazole, indomethacin. Drugs administered by IV push : ampicillin+sulbactam, penicillin G potassium, NaHCO3, ranitidine, epinephrine, furosemide, dexamethasone. Drugs administered by IV infusion for at least 60min : acyclovir, amphotericin B, vancomycin, dobutamine, dopamine, doxapram. After each test, the Y injection site and tube below the Y injection site were visually inspected for precipitation and color change. If no particles or color change was detected, the solution was tested and analyzed by a liquid borne particle analyzer (LBPA). RESULTS: White precipitate formed immediately after Y-site administration : phenytoin, aminophylline (undiluted solution), ampicillin+sulbactam (undiluted solution). Number of particles observed with LBPA exceeded the KP guideline limit immediately after Y-site administration and white precipitate formed after 3-4 hour : ceftriaxone, NaHCO3 (1 : 2 diluted solution). CONCLUSION: These results revealed that several lV drugs prescribed in NICU formed precipitate and had a color change, when mixed with neonatal TPN solutions.

Asunto(s)

RESUMEN

PURPOSE: Because vascular access sites in neonates are limited, intravenous (IV) medications must often be mixed with maintenance fluids, including parenteral nutrient (PN) solutions. This study was done to determine whether IV medications commonly prescribed in the neonatal in- tensive care unit (NICU) are compatible with the two neonatal PN solutions. METHODS: The compatibility of neonatal PN solutions and selected other drugs during Y-site delivery was evaluated. Secondary drugs were administered at selected concentrations, rates and delivery by method commonly used at the NICU. Drugs administered by syringe pump over 30min : amikacin, cefotaxime, ceftriaxone, piperacillin, phenytoin, aminophylline, ceftazidime, fluconazole, indomethacin. Drugs administered by IV push : ampicillin+sulbactam, penicillin G potassium, NaHCO3, ranitidine, epinephrine, furosemide, dexamethasone. Drugs administered by IV infusion for at least 60min : acyclovir, amphotericin B, vancomycin, dobutamine, dopamine, doxapram. After each test, the Y injection site and tube below the Y injection site were visually inspected for precipitation and color change. If no particles or color change was detected, the solution was tested and analyzed by a liquid borne particle analyzer (LBPA). RESULTS: White precipitate formed immediately after Y-site administration : phenytoin, aminophylline (undiluted solution), ampicillin+sulbactam (undiluted solution). Number of particles observed with LBPA exceeded the KP guideline limit immediately after Y-site administration and white precipitate formed after 3-4 hour : ceftriaxone, NaHCO3 (1 : 2 diluted solution). CONCLUSION: These results revealed that several lV drugs prescribed in NICU formed precipitate and had a color change, when mixed with neonatal TPN solutions.

Asunto(s)